CD25+CD45RBlowCD4+ but Not CD25−CD45RBlowCD4+ Cells Inhibit Colitis
| Cells injected . | . | . | |
|---|---|---|---|
| Phenotype . | No. . | Percentage of colitis (n) . | Percentage of weight change . |
| CD45RBhighCD4+ alone | 89 (9) | 78.6 ± 4.9 | |
| CD45RBhighCD4+ | |||
| Plus CD45RBlowCD4+ | 2 × 105 | 0 (5) | 103.3 ± 1.6 |
| Plus CD25+CD45RBlowCD4+ | 2 × 105 | 0 (4) | 105.3 ± 0.8 |
| 1 × 105 | 0 (4) | 107.0 ± 2.5 | |
| 5 × 104 | 0 (5) | 110.3 ± 2.5 | |
| Plus CD25−CD45RBlowCD4+ | 2 × 105 | 38 (8) | 98.5 ± 5.0 |
| 5 × 105 | 60 (10) | 8 6.7 ± 3.5 | |
| CD25+CD45RBlowCD4+ alone | 2 × 105 | 0 (3) | 114.5 ± 6.9 |
| CD25−CD45RBlowCD4+ alone | 2 × 105 | 0 (3) | 107.0 ± 0.6 |
| Cells injected . | . | . | |
|---|---|---|---|
| Phenotype . | No. . | Percentage of colitis (n) . | Percentage of weight change . |
| CD45RBhighCD4+ alone | 89 (9) | 78.6 ± 4.9 | |
| CD45RBhighCD4+ | |||
| Plus CD45RBlowCD4+ | 2 × 105 | 0 (5) | 103.3 ± 1.6 |
| Plus CD25+CD45RBlowCD4+ | 2 × 105 | 0 (4) | 105.3 ± 0.8 |
| 1 × 105 | 0 (4) | 107.0 ± 2.5 | |
| 5 × 104 | 0 (5) | 110.3 ± 2.5 | |
| Plus CD25−CD45RBlowCD4+ | 2 × 105 | 38 (8) | 98.5 ± 5.0 |
| 5 × 105 | 60 (10) | 8 6.7 ± 3.5 | |
| CD25+CD45RBlowCD4+ alone | 2 × 105 | 0 (3) | 114.5 ± 6.9 |
| CD25−CD45RBlowCD4+ alone | 2 × 105 | 0 (3) | 107.0 ± 0.6 |
SCID mice received 4 × 105 CD45RBhigh cells alone or in combination with other subpopulations as indicated. 8 wk after transfer, mice were killed and tissues were taken for histological examination. Data are pooled from two independent experiments. CD45RBhigh versus CD45RBhigh plus CD25+CD45RBlow: P < 0.001; CD45RBhigh versus CD45RBhigh plus CD25−CD45RBlow: not significant.